Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.43 is 88% below its 5-year average of 3.67, near the low end of its 5-year range (0.43–9.06).
As of the fiscal period ended Tuesday, March 31, 2026. 60.23% below its 12-month average of 1.08.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-03-31): 0.43.
QUICK RATIO (ACID-TEST)
0.43
QUICK RATIO (ACID-TEST) AVG TTM
1.08
QUICK RATIO (ACID-TEST) AVG 3Y
1.86
QUICK RATIO (ACID-TEST) AVG 5Y
3.67
QUICK RATIO (ACID-TEST) AVG 10Y
2.12
QUICK RATIO (ACID-TEST) AVG 15Y
2.80
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-60.23%
CURRENT VS 3Y AVG
-76.99%
CURRENT VS 5Y AVG
-88.30%
CURRENT VS 10Y AVG
-79.78%
CURRENT VS 15Y AVG
-84.69%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-87.22%
vs the sector median at left
Traws Pharma, Inc.
Market Cap
$7.92M
Quick Ratio (Acid-Test)
0.43
TTM Avg
1.08
3Y Avg
1.86
5Y Avg
3.67
Market Cap
$7.87M
Quick Ratio (Acid-Test)
13.55
TTM Avg
6.32
3Y Avg
6.80
5Y Avg
6.83
Market Cap
$8.04M
Quick Ratio (Acid-Test)
2.61
TTM Avg
2.11
3Y Avg
2.42
5Y Avg
2.17
Market Cap
$8.05M
Quick Ratio (Acid-Test)
0.10
TTM Avg
0.10
3Y Avg
0.10
5Y Avg
0.10
Market Cap
$7.75M
Quick Ratio (Acid-Test)
5.86
TTM Avg
2.71
3Y Avg
2.06
5Y Avg
3.31
Market Cap
$8.14M
Quick Ratio (Acid-Test)
-71.42
TTM Avg
0.41
3Y Avg
1.44
5Y Avg
1.15
Market Cap
$7.67M
Quick Ratio (Acid-Test)
7.10
TTM Avg
3.48
3Y Avg
3.44
5Y Avg
4.75
Market Cap
$7.64M
Quick Ratio (Acid-Test)
0.18
TTM Avg
0.90
3Y Avg
2.06
5Y Avg
1.76
Market Cap
$7.62M
Quick Ratio (Acid-Test)
14.52
TTM Avg
3.29
3Y Avg
11.30
5Y Avg
10.20
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | $7.92M | 0.43 | 1.08 | 1.86 | 3.67 |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.87M | 13.55 | 6.32 | 6.80 | 6.83 |
| GT Biopharma, Inc. (GTBP)vs › | $8.04M | 2.61 | 2.11 | 2.42 | 2.17 |
| DataMEDS AI, Inc. (MEDS)vs › | $8.05M | 0.10 | 0.10 | 0.10 | 0.10 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | 5.86 | 2.71 | 2.06 | 3.31 |
| HeartSciences Inc. (HSCS)vs › | $8.14M | -71.42 | 0.41 | 1.44 | 1.15 |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.67M | 7.10 | 3.48 | 3.44 | 4.75 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | 0.18 | 0.90 | 2.06 | 1.76 |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | 14.52 | 3.29 | 11.30 | 10.20 |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | 0.60 | 0.62 | 0.79 | 1.04 |
Quick Ratio
0.43
Excludes inventory
Current Ratio
0.43
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-03-31 | 0.43 |
| 2025-12-31 | 0.72 |
| 2025-06-30 | 2.09 |
| 2024-12-31 | 2.16 |
| 2024-06-30 | 1.88 |
| 2023-12-31 | 2.30 |
| 2023-06-30 | 3.46 |
| 2022-12-31 | 4.89 |
| 2022-06-30 | 7.44 |
| 2021-12-31 | 9.06 |
| 2021-06-30 | 5.89 |
| 2020-12-31 | 1.97 |
| 2020-06-30 | 3.20 |
| 2019-12-31 | 2.83 |
| 2019-06-30 | 0.96 |
| 2018-12-31 | 2.11 |
| 2018-06-30 | 3.02 |
| 2017-12-31 | 0.49 |
| 2017-06-30 | 1.62 |
| 2016-12-31 | 2.27 |
| 2016-06-30 | 1.76 |
| 2015-12-31 | 3.05 |
| 2015-06-30 | 2.76 |
| 2014-12-31 | 4.57 |
| 2014-06-30 | 6.18 |
| 2013-12-31 | 10.10 |
| 2013-06-30 | 4.29 |
| 2012-12-31 | 3.28 |
| 2012-06-30 | 0.00 |
